General
Preferred name
ROBALZOTAN
Synonyms
NAD 299 hydrochloride ()
[3H]robalzotan ()
[3H]robalzotan ()
Robalzotan tartrate hydrate ()
NAD-299 ()
AZD-7371 ()
P&D ID
PD050602
CAS
184674-99-5
169758-66-1
Tags
available
drug candidate
Drug indication
Anxiety disorder
Discovery agent
Drug Status
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Selective alpha1B antagonist (Tocris Bioactive Compound Library)
DESCRIPTION Selective, high affinity 5-HT1A antagonist (Tocriscreen Plus)
DESCRIPTION NAD 299 hydrochloride is a 5-HT1A receptor antagonist. It can be used in psychotropic drug development. (BOC Sciences Bioactive Compounds)
Compound Sets
14
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
Guide to Pharmacology
ReFrame library
Tocris Bioactive Compound Library
Tocriscreen Plus
External IDs
30
Properties
(calculated by RDKit )
Molecular Weight
318.17
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
4
Ring Count
4
Aromatic Ring Count
1
cLogP
2.64
TPSA
55.56
Fraction CSP3
0.61
Chiral centers
1.0
Largest ring
6.0
QED
0.93
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Primary Target
5-HT1A Receptors
MOA
Antagonist
serotonin receptor antagonist
Target
HTR1A
Source data